Payments for achievement of various milestones
Mirum Pharmaceuticals, Inc.·Products & Services·1 segment
Breakdown
Segments
VolixibatView metric
| Segment | FY'24 | FY'25 |
|---|---|---|
| Volixibat | $86.5M | $101.5M |
| Total | $86.5M | $101.5M |
All segment values are derived from annual filings.